Literature DB >> 18207581

Adipocytokines in Down's syndrome, an atheroma-free model: Role of adiponectin.

Massimiliano M Corsi1, Giada Dogliotti, Francesca Pedroni, Emanuela Galliera, Alexis E Malavazos, Roberto Villa, Martina Chiappelli, Federico Licastro.   

Abstract

Down's syndrome (DS) is the most frequent chromosomal aberration in men. Moreover DS is considered an atheroma-free model. Plasma levels of interleukin-6 (IL-6), tumor necrosis factor-alpha high sensitivity (hsTNF-alpha), leptin and adiponectin from non-demented DS subjects of three different age cohorts (2-14, 20-50 and above 60 years) and healthy controls were measured. No clinical and sub-clinical inflammation was apparent in DS patients. Plasma levels of hsTNF-alpha, IL-6 and leptin were higher in children than in adult and old DS subjects. Instead, serum levels of adiponectin were increased in older DS patients than in DS children and adults. High levels of circulating adiponectin might protect DS from clinical complications of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18207581     DOI: 10.1016/j.archger.2007.10.011

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  8 in total

1.  Survival and morbidity outcomes for very low birth weight infants with Down syndrome.

Authors:  Nansi S Boghossian; Nellie I Hansen; Edward F Bell; Barbara J Stoll; Jeffrey C Murray; Abbot R Laptook; Seetha Shankaran; Michele C Walsh; Abhik Das; Rosemary D Higgins
Journal:  Pediatrics       Date:  2010-11-22       Impact factor: 7.124

Review 2.  Cardiovascular Prevention Among Young Adults with Congenital Heart Disease.

Authors:  Matthew R Lippmann; Ami B Bhatt
Journal:  Curr Atheroscler Rep       Date:  2022-04-30       Impact factor: 5.967

3.  A cross-sectional study of the phenotypes of obesity and insulin resistance in adults with down syndrome.

Authors:  Diego Real de Asua; Pedro Parra; Ramón Costa; Fernando Moldenhauer; Carmen Suarez
Journal:  Diabetes Metab J       Date:  2014-12-15       Impact factor: 5.376

Review 4.  Meta-analysis of metabolites involved in bioenergetic pathways reveals a pseudohypoxic state in Down syndrome.

Authors:  Laszlo Pecze; Elisa B Randi; Csaba Szabo
Journal:  Mol Med       Date:  2020-11-09       Impact factor: 6.354

5.  Comprehensive phenotypic analysis of the Dp1Tyb mouse strain reveals a broad range of Down syndrome-related phenotypes.

Authors:  Eva Lana-Elola; Heather Cater; Sheona Watson-Scales; Simon Greenaway; Jennifer Müller-Winkler; Dorota Gibbins; Mihaela Nemes; Amy Slender; Tertius Hough; Piia Keskivali-Bond; Cheryl L Scudamore; Eleanor Herbert; Gareth T Banks; Helene Mobbs; Tara Canonica; Justin Tosh; Suzanna Noy; Miriam Llorian; Patrick M Nolan; Julian L Griffin; Mark Good; Michelle Simon; Ann-Marie Mallon; Sara Wells; Elizabeth M C Fisher; Victor L J Tybulewicz
Journal:  Dis Model Mech       Date:  2021-10-15       Impact factor: 5.732

Review 6.  Adults with Down syndrome challenge another paradigm: When aging no longer entails arterial hypertension.

Authors:  Emilia Roy-Vallejo; José María Galván-Román; Fernando Moldenhauer; Diego Real de Asúa
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-09       Impact factor: 3.738

7.  Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis.

Authors:  Elena Vianello; Giada Dogliotti; Elena Dozio; Massimiliano Marco Corsi Romanelli
Journal:  Immun Ageing       Date:  2013-01-22       Impact factor: 6.400

Review 8.  Down Syndrome, Obesity, Alzheimer's Disease, and Cancer: A Brief Review and Hypothesis.

Authors:  Daniel W Nixon
Journal:  Brain Sci       Date:  2018-03-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.